Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema
| Autor: | Amin Kanani, Georges-Etienne Rivard, Palinder Kamra, Zhi Yu Xiang, Paul K. Keith, Karen A. Valentine, Sean R. Mace, Dumitru Moldovan, Kristylea Brosz, Richard Warrington, Azza Hamed, Inmaculada Martinez-Saguer, Andrew C. Issekutz, Lucia Celeste, Christine McCusker, Ellie Tsai, Man-Chiu Poon, Bazir Serushago, Laurence Bouillet, Erik Waage Nielsen, Bruce L. Zuraw, Teresa Caballero, Gina Lacuesta, Eric Wagner, Jeanne Burnham, István Nagy, Susan Waserman, Wolfhart Kreuz, E. Rusicke, Bruce Ritchie, Peter J. Späth, Lilian Varga, Eric Leith, Christoph Bucher, Chrystyna Kalicinsky, Michael M. Frank, Donald Stark, Doris Neurath, Emel Aygören-Pürsün, David Page, John M. Dean, Marco Cicardi, Lorenza C. Zingale, George Füst, Karen Binkley, Henry Li, Patrik Nordenfelt, Konrad Bork, R. Robert Schellenberg, Tom Bowen, Henriette Farkas, Silvia Marchesin, Jacques Hébert, Hilary Longhurst, George Harmat, Peggy Adomaitis, Sara Smith-Foltz, William H. Yang |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Pulmonary and Respiratory Medicine
Consensus algorithm medicine.medical_specialty Canada C1 inhibitor deficiency Consensus Development Conferences as Topic International Cooperation Immunology MEDLINE Ecallantide medicine Immunology and Allergy Humans Hungary business.industry Angioedemas Hereditary State of the art review Evidence-based medicine medicine.disease Blood Disorder Family medicine Hereditary angioedema Controlled Clinical Trials as Topic business Algorithms medicine.drug |
| Zdroj: | Scopus-Elsevier |
| ISSN: | 1081-1206 |
| Popis: | Background We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) in 2004. Objective To ensure that this consensus remains current. Methods In collaboration with the Canadian Network of Rare Blood Disorder Organizations, we held the second Canadian Consensus discussion with our international colleagues in Toronto, Ontario, on February 3, 2006, and reviewed its content at the Fifth C1 Inhibitor Deficiency Workshop in Budapest on June 2, 2007. Papers were presented by international investigators, and this consensus algorithm approach resulted. Results This consensus algorithm outlines the approach recommended for the diagnosis, therapy, and management of HAE, which was agreed on by the authors of this report. This document is only a consensus algorithm approach and continues to require validation. As such, participants agreed to make this a living 2007 algorithm, a work in progress, and to review its content at future international HAE meetings. Conclusions There is a paucity of double-blind, placebo-controlled trials on the treatment of HAE, making levels of evidence to support the algorithm less than optimal. Controlled trials currently under way will provide further insight into the management of HAE. As with our Canadian 2003 Consensus, this 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of HAE was formed through the meeting and agreement of patient care professionals along with patient group representatives and individual patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|